Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Feb 11.
Published in final edited form as: Chem Commun (Camb). 2018 Jan 4;54(12):1429–1432. doi: 10.1039/c7cc08928g

Catalytic aziridination with alcoholic substrates via a chromium tetracarbene catalyst

C Luke Keller a, Jesse L Kern a,, Bradley D Terry a, Sharani Roy a, David M Jenkins a
PMCID: PMC6136250  NIHMSID: NIHMS932250  PMID: 29299550

Abstract

The first examples of aziridination catalysis with a chromium complex are communicated. This tetracarbene chromium complex provides novel catalytic aziridination reactions with protic substrates such as alcohols or amines on the alkene or organic azide and is the most effective catalyst at low alkene loading for aliphatic alkenes to date.


The protean reactivity of aziridines is derived from both the strain of their three-membered ring as well as the reactivity of the nitrogen atom integrated within.13 These combined properties have made aziridines invaluable for setting stereochemistry through ring opening reactions,46 and for production of larger N-heterocycles, such as 1,2,4-triazines or pyrroloindolines, via ring expansion.710 Justifiably, aziridination has been employed in the synthesis of pharmaceuticals and natural products.4, 11, 12

Since aziridines can be highly effective for a variety of synthetic tasks, multiple new routes for their synthesis have been developed recently.1315 Due to the wide availability of the reagents, one preferred method is the combination of alkenes and organic azides, in a C2 + N1 reaction.15, 16 To this end, Zhang, Che, Cenini, Gallo, Betley and others developed a variety of catalysts, notably porphyrins and half-porphyrins that are effective for aziridination.1622

Despite the recent improvements for this reaction methodology, there are several limitations to the C2 + N1 aziridination with organic azides which have prohibited the reaction’s widespread application in synthetic chemistry. Typically, aziridination reactions require excess alkene relative to the organic azide.19, 23 The high alkene loading requirement is particularly true for aliphatic alkenes as opposed to conjugated alkenes such as styrene.22, 24 In the original iron catalyst pioneered by our group, high alkene loading was required to suppress formation of the metallotetrazene side-product.25 More critically for medicinal chemists, functional group tolerance has been limited to non-protic functional groups such as nitros or halides.16, 19 Both of these limitations must be overcome if high value-added targets are to be synthesized efficiently directly from organic azides and alkenes.

In this communication, we present the results for aziridination catalysis with a tetracarbene chromium(III) complex.26 This chromium complex is the first C2 + N1 aziridination catalyst on any group six metal. Unlike our previous iron systems,24 the chromium complex is effective for aziridination at low alkene loadings. Furthermore, this catalyst is modestly effective at aziridination with protic functional groups on the alkene or azide, which has not been observed with any previous aziridination catalysis using organic azides. Finally, we present some preliminary observations on why the chromium catalyst is effective at low alkene loading as compared to the original iron catalyst and other similar chromium systems.

Since the success of our initial iron tetracarbene catalyst at aziridination24 and our development of a methodology to prepare a wide variety of tetracarbene complexes,26 we examined each additional complex for catalytic aziridination. While most were unreactive toward organic azides, the octahedral chromium complex [(Me,EtTCPh)Cr(Cl)2](PF6) (1) proved effective at aziridination with aryl azides in a similar manner to the previously reported [(Me,EtTCPh)Fe(NCCH3)2](PF6)2 (2). A general aziridination reaction of aryl azides and alkenes with these catalysts is shown in Scheme 1.

Scheme 1.

Scheme 1

Example catalytic aziridination reaction with Cr (1) or Fe (2) catalysts.

Optimizing the test conditions with 1 found that this catalyst was effective at low alkene loading. A test reaction of 1-decene and p-tolyl azide in a 1:1 ratio plus 1 at 2% catalyst loading in acetonitrile at 85 °C gave an isolated yield of 26% for 2-octyl-1-(p-tolyl)aziridine, 3 (Table 1, Entry 1). A modest increase in the alkene loading to a 3:1 ratio boosted the yield of 3 to 61% (Entry 2). Further increases in alkene loading only had trivial increases in the yield (Entry 3).24 A pair of control reactions without 1 present produced 3 in only 4.7% and 12.3% yields for 1:1 and 3:1 alkene to azide ratios, respectively (Entries 4 and 5). Notably, the same reaction with 2 as catalyst was ineffective (Entry 6).

Table 1.

Testing catalytic conditions for various alkene loadings.

Entrya Catalystb Azide/Alkene ratio Catalyst Loading Isolated Yield of 3
1 1 1/1 2% 26.3
2 1 3/1 2% 61.1
3 1 10/1 2% 67.2
4 1 1/1 0% 4.7
5 1 3/1 0% 12.3
6 2 3/1 2% 9.7
a

4 mL of CH3CN as solvent at 85°C for 3 days. 1-decene (variable) and p-tolyl azide (~100 mg) were used in each test reaction as shown in Scheme 1.

b

0.01-0.02 mmol of 1 or 2 was used for each reaction.

Test conditions for reactions with 1 also explored the effect of solvent on the reaction (ESI) under the same conditions as shown in Table 1, Entry 2. Non-polar solvents, such as toluene, showed no catalytic activity. Polar solvents including DMF, DMSO, and pyridine gave yields for the test reaction of 46%, 13%, and 31%, respectively, which were all lower than the previously described reaction in acetonitrile.

Initial investigations on catalytic aziridination focused on examples with either no functional groups or aprotic functional groups (ESI, Table S1). 9-(p-tolyl)-9-azabicyclo[6.1.0]nonane, 4, was prepared in 52% yield from 1, tolyl azide, and only three equivalents of cyclooctene, while the original iron catalyst, 2, required neat cyclooctene for the same reaction.24 In a similar manner, 1-(4-methoxyphenyl)-2-octylaziridine, 5,4-(2-octylaziridin-1-yl)benzaldehyde, 6, and 1-(4-chlorophenyl)-2-octylaziridine, 7, could be prepared in modest yields at low alkene loading (56%, 40%, and 35%, respectively). Finally, as a test with a functionalized alkene, we tested 10-undecenoate with p-tolyl azide and 1 to yield ethyl 9-(1-(p-tolyl)aziridin-2-yl)nonanoate, 8, albeit in low isolated yield of 23%.

While catalysis reactions with aprotic organic azides and alkenes have been an intense area of research in the lastdecade,16, 19, 20 no fully characterized aziridines containing protic functional groups have been reported via C2 + N1 catalysis of an alkene and organic azide.27 Protic functional groups are commonly found in natural products that contain aziridines.28 The chromium catalyst 1 was modestly effective for several of these reactions (Table 2). Replacing 1-decene with 9-decenol led to the formation of 8-(1-(p-tolyl)aziridin-2-yl)octanol, 9, in 32% isolated yield. A similar reaction with 2 as the catalyst yielded no aziridine which is consistent with our previous results that show that our iron catalysts are not effective with protic functional groups.

Table 2.

Catalytic reaction with 1 and protic functionalized alkenes and organic azides.

Entrya Alkene Azide Product Isolated Yield
1 graphic file with name nihms932250t1.jpg graphic file with name nihms932250t2.jpg graphic file with name nihms932250t3.jpg 31.8
2 graphic file with name nihms932250t4.jpg graphic file with name nihms932250t5.jpg graphic file with name nihms932250t6.jpg 41.3
3 graphic file with name nihms932250t7.jpg graphic file with name nihms932250t8.jpg graphic file with name nihms932250t9.jpg 26.1
4 graphic file with name nihms932250t10.jpg graphic file with name nihms932250t11.jpg graphic file with name nihms932250t12.jpg 39.1
5 graphic file with name nihms932250t13.jpg graphic file with name nihms932250t14.jpg graphic file with name nihms932250t15.jpg 35.0
6 graphic file with name nihms932250t16.jpg graphic file with name nihms932250t17.jpg graphic file with name nihms932250t18.jpg 30.1
a

4 mL of CH3CN as solvent at 85°C for 3 days. 1 employed as catalyst at 2% loading with a 3/1 alkene to azide ratio.

Moving to a shorter chain alcohol led to an unexpected product. The reaction with 4-pentenol, p-tolyl azide and 1 did not yield the expected aziridine, but in fact 4-methyl-N-((tetrahydrofuran-2-yl)methyl)aniline, 10, which has been previously prepared by Buchwald via a coupling reaction of p-tolylboronic acid and S-(+)-tetrahydrofurylmethyl amine.29 Compound 10 could be formed through from an intramolecular ring opening nucleophilic attack of the alcohol on the expected aziridine followed by a proton shift with 1 acting as a catalyst. Several early metal catalysts have been designed for this class of reaction including stereoselective examples by Kobayashi.30 Alternatively, a carboradical intermediate could be formed during formation of the aziridine which would be attacked by the alcohol. Placing alcohols off an aryl ring gave similar products. An alcohol in the para position of the organic azide lead to aziridine formation (11), while an alcohol in the ortho position again led to a ring opening and rearrangement (12) in a manner analogous to 10.

Additional tests expanded the scope beyond placing an alcohol on the alkene (Table 2). Alcohols on the organic azide were successful as well. A catalytic reaction with 3-azidophenol and 1-decene and 1 gave the expected aziridine, 3-(2-octylaziridin-1-yl)phenol, 13, in 35% isolated yield. Notably, a reaction with a secondary amine was also successful. N-allylaniline was combined with p-tolyl azide and 1, to yield N-((1-(p-tolyl)aziridin-2-yl)methyl)aniline, 14, in 30% yield. The only protic functional group tested that was completely ineffective was carboxylic acids. A reaction with 9-decenoic acid under the standard catalytic conditions yielded no aziridine.

Since catalytic aziridination often yields a mixture of products, particularly amination products, we decided to quantitate the balance of products for selected reactions.17 We tested the formation of 9 and 13 under the same catalytic conditions in CD3CN and integrated the products versus an internal standard of CH2Br2 (Table 3). In the case of 9, we noted a 50% conversion to the desired azide, which shows that the low yield of 9 is primarily due to the challenging separation. In addition to the aziridine, both unreacted azide and alkene were present in 30% and 250% yield, respectively. In addition, some tolyl azide had also been reduced to the respective amine (18% yield); amine side products in aziridination have been previously reported.17 Notably, neither vinylic or allylic amination products were detected in the NMR. A similar reaction to form 13 showed the same products in qualitatively similar ratios.

Table 3.

Quantification of product distribution at conclusion of reactions by NMR integration.

Entrya Azididine Conversion/Isolated Yield Remaining Azide/Alkeneb Amine
1 graphic file with name nihms932250t19.jpg 50/31.8 30/250 18
2 graphic file with name nihms932250t20.jpg 44/35.0 28/231 28
a

4 mL of CD3CN as solvent at 85°C for 3 days. 1 employed as catalyst at 2% loading with a 3/1 alkene to azide ratio. CH2Br2 was employed as an internal standard.

b

Three equivalents of alkene were employed so multiple equivalents remained.

The relative effectiveness of 1 at low alkene loading as compared to 2 led us to consider their mechanistic differences. First, compound 1, like 2, is a saturated octahedral complex. While 2 exchanges its solvent ligands rapidly,24 1 would need to lose a chloride to have an open site (Scheme 2). We believe that the different rates of catalysis for 1 as a function of solvent are related to this effect (ESI). Non-polar solvents are ineffective for catalysis, while acetonitrile is the most favorable. Once a site is open, an organic azide could react to form a metal imide. DFT calculations (see ESI) show that this reaction is highly favorable by ΔG = −57.4 kcal/mol to form a species with one chloride removed (Scheme 2). At this point, the chromium imide intermediate could either react with a second azide to form a metallotetrazene or an alkene to form an aziridine. DFT calculations show that the formation of aziridine is more favorable (ΔG = −43.9 kcal/mol) than the formation of metallotetrazene (ΔG = −33.8 kcal/mol). This theoretical result is consistent with our observation that 1 is effective at low alkene loading unlike 2.

Scheme 2.

Scheme 2

Proposed catalytic cycle for 1. Calculated free energies (ΔG) for the species are shown in blue in units of kcal/mol.

The formation of metallotetrazene appears to be disfavored solely by the trans chloride ligand on 1. This supposition is supported by DFT calculations which show that the purported imide intermediate is favorable both with and without a trans chloride, but the presence of the trans chloride destabilizes a metallotetrazene relative to the formation of aziridine (Figure S21 and S22, ESI). If the trans chloride is removed, the relative free energy of the tetrazene drops to ΔG = −72.9 kcal/mol (versus ΔG = −33.8 kcal/mol with chloride) which would make metallotetrazene formation highly favorable. These theoretical results were tested with a series of reactions with halide abstracting reagents. Addition of two equivalents of halide abstraction reagent, in this case a silver ion, during a catalytic reaction completely stops aziridination. A single equivalent of halide abstractor (either Tl or Ag) reduced the yield of aziridine (23% and 18%, respectively). These low yields suggest that it may be easier to remove the second equivalent of chloride during the catalytic cycle, perhaps upon formation of the chromium imide species that would have a strong trans effect.

A key question is why catalyst 1 is effective at aziridination while other chromium systems have not reported this reaction. Similar catalytic oxygen atom transfer oxidations with chromium are known, but rare. A few epoxidations with Cr(III) systems are known (and proceed through Cr(V) oxos),31, 32 and the yields are modest (less than 50%). Turning to imide analogs, Cr(V) imides have been reacted with phosphines to give the phosphiimide,33 but in some cases Cr(V) imides have been isolated for which no reactivity was reported. The most prominent studies for Cr(V) have featured auxiliary ligands such as salen, porphyrin, or corroles.34, 35 Notably, our recent research with a similar tetracarbene Cr(IV) imide complex demonstrates non-catalytic imide transfer.36 We suspect that 1 is more reactive both due to the stronger donor NHCs and the key trans chloride ligand. The former explains why relatively weak oxidants like aryl azides are reactive as opposed to only stronger oxidants that have been previously employed (like PhIO). The latter, the lack of a ligand trans to the imide, is a key feature which promotes reactivity with an alkene as shown in our DFT calculations. None of the previous examples of chromium group transfer catalysis feature a ligand that is trans to the purported imide.

In conclusion, we have demonstrated a novel chromium catalyst for C2 + N1 aziridination, the first on this metal. This catalyst is effective at low alkene loading, unlike our initial iron catalysts, and is the most effective catalyst for aliphatic alkenes at low loading to date. More impressively, this chromium catalyst is the first example that is effective with protic functional groups, such as alcohols or amines, albeit in modest isolated yields. Including these functional groups on aziridines is critical for developing improved synthetic methods in medicinal chemistry. These insights are critical for designing the next generation of C2 + N1 aziridination catalysts and suggest that additional chromium complexes should be tested as catalysts for aziridination.

Supplementary Material

esi

Acknowledgments

We thank S. Alan Cramer for collecting a high resolution mass spectrum. C. L. K. and D. M. J. are grateful to the NSF (CAREER grant CHE-1254536) for financial support. B. D. T. is grateful to the NSF for undergraduate summer support through UT’s REU program (NSF CHE-1560033). S. R. and D. M. J. are grateful to the NIH (R15GM117494-01A). J. L. K. and S. R. are grateful to the University of Tennessee for financial support.

Footnotes

Electronic Supplementary Information (ESI) available: Complete experimental details, NMR spectra, and DFT calculations. See DOI: 10.1039/x0xx00000x

Notes and references

  • 1.Callebaut G, Meiresonne T, De Kimpe N, Mangelinckx S. Chem Rev. 2014;114:7954–8015. doi: 10.1021/cr400582d. [DOI] [PubMed] [Google Scholar]
  • 2.Degennaro L, Trinchera P, Luisi R. Chem Rev. 2014;114:7881–7929. doi: 10.1021/cr400553c. [DOI] [PubMed] [Google Scholar]
  • 3.Huang CY, Doyle AG. Chem Rev. 2014;114:8153–8198. doi: 10.1021/cr500036t. [DOI] [PubMed] [Google Scholar]
  • 4.Zhou Y, Mukherjee M, Gupta AK, Wulff WD. Org Lett. 2017;19:2230–2233. doi: 10.1021/acs.orglett.7b00697. [DOI] [PubMed] [Google Scholar]
  • 5.Sengoden M, Bhowmick A, Punniyamurthy T. Org Lett. 2017;19:158–161. doi: 10.1021/acs.orglett.6b03458. [DOI] [PubMed] [Google Scholar]
  • 6.Woods BP, Orlandi M, Huang CY, Sigman MS, Doyle AG. J Am Chem Soc. 2017;139:5688–5691. doi: 10.1021/jacs.7b03448. [DOI] [PubMed] [Google Scholar]
  • 7.Crespin L, Biancalana L, Morack T, Blakemore DC, Ley SV. Org Lett. 2017;19:1084–1087. doi: 10.1021/acs.orglett.7b00101. [DOI] [PubMed] [Google Scholar]
  • 8.Chai Z, Zhu YM, Yang PJ, Wang S, Wang S, Liu Z, Yang G. J Am Chem Soc. 2015;137:10088–10091. doi: 10.1021/jacs.5b05820. [DOI] [PubMed] [Google Scholar]
  • 9.Rivinoja DJ, Gee YS, Gardiner MG, Ryan JH, Hyland CJT. ACS Catalysis. 2017;7:1053–1056. [Google Scholar]
  • 10.Wang L, Yang D, Han F, Li D, Zhao D, Wang R. Org Lett. 2015;17:176–179. doi: 10.1021/ol503455r. [DOI] [PubMed] [Google Scholar]
  • 11.Mulcahy JV, Walker JR, Merit JE, Whitehead A, Du Bois J. J Am Chem Soc. 2016;138:5994–6001. doi: 10.1021/jacs.6b02343. [DOI] [PubMed] [Google Scholar]
  • 12.Oh HS, Kang HY. J Org Chem. 2012;77:8792–8796. doi: 10.1021/jo3015853. [DOI] [PubMed] [Google Scholar]
  • 13.McNally A, Haffemayer B, Collins BSL, Gaunt MJ. Nature. 2014;510:129–133. doi: 10.1038/nature13389. [DOI] [PubMed] [Google Scholar]
  • 14.Jat JL, Paudyal MP, Gao H, Xu QL, Yousufuddin M, Devarajan D, Ess DH, Kürti L, Falck JR. Science. 2014;343:61–65. doi: 10.1126/science.1245727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jenkins DM. Synlett. 2012;23:1267–1270. [Google Scholar]
  • 16.Chandrachud PP, Bass HM, Jenkins DM. Organometallics. 2016;35:1652–1657. [Google Scholar]
  • 17.Caselli A, Gallo E, Fantauzzi S, Morlacchi S, Ragaini F, Cenini S. Eur J Inorg Chem. 2008;2008:3009–3019. [Google Scholar]
  • 18.Jiang H, Lang K, Lu H, Wojtas L, Zhang XP. J Am Chem Soc. 2017;139:9164–9167. doi: 10.1021/jacs.7b05778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fantauzzi S, Gallo E, Caselli A, Piangiolino C, Ragaini F, Cenini S. Eur J Org Chem. 2007;2007:6053–6059. [Google Scholar]
  • 20.Jin LM, Xu X, Lu H, Cui X, Wojtas L, Zhang XP. Angew Chem Int Ed. 2013;52:5309–5313. doi: 10.1002/anie.201209599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.King ER, Hennessy ET, Betley TA. J Am Chem Soc. 2011;133:4917–4923. doi: 10.1021/ja110066j. [DOI] [PubMed] [Google Scholar]
  • 22.Liu Y, Che CM. Chem Eur J. 2010;16:10494–10501. [Google Scholar]
  • 23.Piangiolino C, Gallo E, Caselli A, Fantauzzi S, Ragaini F, Cenini S. Eur J Org Chem. 2007;2007:743–750. [Google Scholar]
  • 24.Cramer SA, Jenkins DM. J Am Chem Soc. 2011;133:19342–19345. doi: 10.1021/ja2090965. [DOI] [PubMed] [Google Scholar]
  • 25.Cramer SA, Hernandez Sanchez R, Brakhage DF, Jenkins DM. Chem Commun. 2014;50:13967–13970. doi: 10.1039/c4cc05124f. [DOI] [PubMed] [Google Scholar]
  • 26.Lu Z, Cramer SA, Jenkins DM. Chem Sci. 2012;3:3081–3087. [Google Scholar]
  • 27.Fantauzzi S, Gallo E, Caselli A, Ragaini F, Macchi P, Casati N, Cenini S. Organometallics. 2005;24:4710–4713. [Google Scholar]
  • 28.Coleman RS, Kong JS. J Am Chem Soc. 1998;120:3538–3539. [Google Scholar]
  • 29.Antilla JC, Buchwald SL. Org Lett. 2001;3:2077–2079. doi: 10.1021/ol0160396. [DOI] [PubMed] [Google Scholar]
  • 30.Arai K, Lucarini S, Salter MM, Ohta K, Yamashita Y, Kobayashi S. J Am Chem Soc. 2007;129:8103–8111. doi: 10.1021/ja0708666. [DOI] [PubMed] [Google Scholar]
  • 31.Hess JS, Leelasubcharoen S, Rheingold AL, Doren DJ, Theopold KH. J Am Chem Soc. 2002;124:2454–2455. doi: 10.1021/ja0167553. [DOI] [PubMed] [Google Scholar]
  • 32.Siddall TL, Miyaura N, Huffman JC, Kochi JK. J Chem Soc, Chem Commun. 1983:1185–1186. [Google Scholar]
  • 33.Edwards NY, Eikey RA, Loring MI, Abu-Omar MM. Inorg Chem. 2005;44:3700–3708. doi: 10.1021/ic0484506. [DOI] [PubMed] [Google Scholar]
  • 34.Zdilla MJ, Abu-Omar MM. J Am Chem Soc. 2006;128:16971–16979. doi: 10.1021/ja0665489. [DOI] [PubMed] [Google Scholar]
  • 35.Bendix J, Anthon C, Schau-Magnussen M, Brock-Nannestad T, Vibenholt J, Rehman M, Sauer SPA. Angew Chem Int Ed. 2011;50:4480–4483. doi: 10.1002/anie.201008153. [DOI] [PubMed] [Google Scholar]
  • 36.Elpitiya GR, Malbrecht BJ, Jenkins DM. Inorg Chem. 2017;56:14101–14110. doi: 10.1021/acs.inorgchem.7b02253. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

esi

RESOURCES